108 related articles for article (PubMed ID: 27810320)
1. TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells.
Wang PY; Zeng WJ; Liu J; Wu YL; Ma Y; Zeng Z; Pang JY; Zhang XK; Yan X; Wong AST; Zeng JZ
Biochem Pharmacol; 2017 Jan; 124():19-28. PubMed ID: 27810320
[TBL] [Abstract][Full Text] [Related]
2. Antagonist effect of triptolide on AKT activation by truncated retinoid X receptor-alpha.
Lu N; Liu J; Liu J; Zhang C; Jiang F; Wu H; Chen L; Zeng W; Cao X; Yan T; Wang G; Zhou H; Lin B; Yan X; Zhang XK; Zeng JZ
PLoS One; 2012; 7(4):e35722. PubMed ID: 22545132
[TBL] [Abstract][Full Text] [Related]
3. NSC-640358 acts as RXRα ligand to promote TNFα-mediated apoptosis of cancer cell.
Chen F; Chen J; Lin J; Cheltsov AV; Xu L; Chen Y; Zeng Z; Chen L; Huang M; Hu M; Ye X; Zhou Y; Wang G; Su Y; Zhang L; Zhou F; Zhang XK; Zhou H
Protein Cell; 2015 Sep; 6(9):654-666. PubMed ID: 26156677
[TBL] [Abstract][Full Text] [Related]
4. Regulation of proteolytic cleavage of retinoid X receptor-α by GSK-3β.
Gao W; Liu J; Hu M; Huang M; Cai S; Zeng Z; Lin B; Cao X; Chen J; Zeng JZ; Zhou H; Zhang XK
Carcinogenesis; 2013 Jun; 34(6):1208-15. PubMed ID: 23389291
[TBL] [Abstract][Full Text] [Related]
5. Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.
Zeng Z; Sun Z; Huang M; Zhang W; Liu J; Chen L; Chen F; Zhou Y; Lin J; Huang F; Xu L; Zhuang Z; Guo S; Alitongbieke G; Xie G; Xu Y; Lin B; Cao X; Su Y; Zhang XK; Zhou H
Cancer Res; 2015 May; 75(10):2049-60. PubMed ID: 25795708
[TBL] [Abstract][Full Text] [Related]
6. NSAID sulindac and its analog bind RXRalpha and inhibit RXRalpha-dependent AKT signaling.
Zhou H; Liu W; Su Y; Wei Z; Liu J; Kolluri SK; Wu H; Cao Y; Chen J; Wu Y; Yan T; Cao X; Gao W; Molotkov A; Jiang F; Li WG; Lin B; Zhang HP; Yu J; Luo SP; Zeng JZ; Duester G; Huang PQ; Zhang XK
Cancer Cell; 2010 Jun; 17(6):560-73. PubMed ID: 20541701
[TBL] [Abstract][Full Text] [Related]
7. Targeting truncated RXRα for cancer therapy.
Zhang X; Zhou H; Su Y
Acta Biochim Biophys Sin (Shanghai); 2016 Jan; 48(1):49-59. PubMed ID: 26494413
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic potential of truncated RXRα during colitis-associated colorectal tumorigenesis by promoting IL-6-STAT3 signaling.
Ye X; Wu H; Sheng L; Liu YX; Ye F; Wang M; Zhou H; Su Y; Zhang XK
Nat Commun; 2019 Apr; 10(1):1463. PubMed ID: 30931933
[TBL] [Abstract][Full Text] [Related]
9. Overview of the structure-based non-genomic effects of the nuclear receptor RXRα.
Chen L; Wu L; Zhu L; Zhao Y
Cell Mol Biol Lett; 2018; 23():36. PubMed ID: 30093910
[TBL] [Abstract][Full Text] [Related]
10. Triptolide inhibits viability and induces apoptosis in liver cancer cells through activation of the tumor suppressor gene p53.
Sun YY; Xiao L; Wang D; Ji YC; Yang YP; Ma R; Chen XH
Int J Oncol; 2017 Mar; 50(3):847-852. PubMed ID: 28098861
[TBL] [Abstract][Full Text] [Related]
11. Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway.
Cheng X; Shi W; Zhao C; Zhang D; Liang P; Wang G; Lu L
Mol Med Rep; 2016 Apr; 13(4):3257-64. PubMed ID: 26935527
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of tetrazole-containing RXRα ligands as anticancer agents.
Yan Z; Chong S; Lin H; Yang Q; Wang X; Zhang W; Zhang X; Zeng Z; Su Y
Eur J Med Chem; 2019 Feb; 164():562-575. PubMed ID: 30634084
[TBL] [Abstract][Full Text] [Related]
13. Triptolide suppresses interleukin-1beta-induced human beta-defensin-2 mRNA expression through inhibition of transcriptional activation of NF-kappaB in A549 cells.
Jang BC; Lim KJ; Choi IH; Suh MH; Park JG; Mun KC; Bae JH; Shin DH; Suh SI
Int J Mol Med; 2007 May; 19(5):757-63. PubMed ID: 17390080
[TBL] [Abstract][Full Text] [Related]
14. Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα.
Chen L; Aleshin AE; Alitongbieke G; Zhou Y; Zhang X; Ye X; Hu M; Ren G; Chen Z; Ma Y; Zhang D; Liu S; Gao W; Cai L; Wu L; Zeng Z; Jiang F; Liu J; Zhou H; Cadwell G; Liddington RC; Su Y; Zhang XK
Nat Commun; 2017 Jul; 8():16066. PubMed ID: 28714476
[TBL] [Abstract][Full Text] [Related]
15. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells.
Jiang XH; Wong BC; Lin MC; Zhu GH; Kung HF; Jiang SH; Yang D; Lam SK
Oncogene; 2001 Nov; 20(55):8009-18. PubMed ID: 11753684
[TBL] [Abstract][Full Text] [Related]
16. Triptolide inhibits tumor promoter-induced uPAR expression via blocking NF-kappaB signaling in human gastric AGS cells.
Chang HJ; Kim MH; Baek MK; Park JS; Chung IJ; Shin BA; Ahn BW; Jung YD
Anticancer Res; 2007; 27(5A):3411-7. PubMed ID: 17970088
[TBL] [Abstract][Full Text] [Related]
17. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
[TBL] [Abstract][Full Text] [Related]
18. Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53.
Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishiyama H
Oncogene; 2008 Jul; 27(33):4603-14. PubMed ID: 18391982
[TBL] [Abstract][Full Text] [Related]
19. Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.
Chen L; Wang ZG; Aleshin AE; Chen F; Chen J; Jiang F; Alitongbieke G; Zeng Z; Ma Y; Huang M; Zhou H; Cadwell G; Zheng JF; Huang PQ; Liddington RC; Zhang XK; Su Y
Chem Biol; 2014 May; 21(5):596-607. PubMed ID: 24704507
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and SAR study of modulators inhibiting tRXRα-dependent AKT activation.
Wang ZG; Chen L; Chen J; Zheng JF; Gao W; Zeng Z; Zhou H; Zhang XK; Huang PQ; Su Y
Eur J Med Chem; 2013 Apr; 62():632-48. PubMed ID: 23434637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
